StockNews.AI
DNB
StockNews.AI
148 days

DNB Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Dun & Bradstreet to Clearlake Capital

1. DNB agreed to be sold to Clearlake Capital for $9.15 per share. 2. The sale price is below Wall Street analysts' price targets. 3. The deal is significantly lower than DNB's 52-week high of $12.95. 4. An investigation questions the fairness of the sale price. 5. DNB shareholders are encouraged to discuss their legal rights.

4m saved
Insight
Article

FAQ

Why Very Bearish?

The sale price of $9.15 is significantly below market expectations, indicating undervaluation. Previous instances, like the case of Verso's buyout at a low offer compared to analyst targets, saw substantial stock depreciation post-announcement.

How important is it?

The investigation directly ties to potential loss of shareholder value from the sale price's unfairness, creating serious implications for DNB shareholders.

Why Short Term?

The immediate negative sentiment from the investigation and undervalued sale price will likely impact stock price in the near term. Historical trends show such deals result in stock reactions shortly after announcements.

Related Companies

CLRKDBRBCGS
MONSEY, N.Y., March 24, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Dun & Bradstreet Holdings, Inc. (NYSE: DNB) (“DNB”) to Clearlake Capital for $9.15 per share in cash. Notably, as detailed below, the sale price is below the price target for DNB of at least seven Wall Street analysts (source: TipRanks). Additionally, the sale price is well below DNB’ 52-week high of $12.95 per share, and thus the deal appears highly opportunistic. If you remain a DNB shareholder and question the fairness of the price, you may contact our firm at the following link to discuss your legal rights at no charge: https://wohlfruchter.com/cases/dun-bradstreet-holdings/ Alternatively, you may contact us by phone at 866-833-6245, or via email at alerts@wohlfruchter.com. Why is there an investigation?On March 24, 2025, DNB announced that it had agreed to be sold to Clearlake Capital for $9.15 per share in cash. Notably, the sale price is below the price target for DNB of at least seven Wall Street analysts following DNB: Faiza Alwy of Deutsche Bank ($17.00 per share target)Surinder Thind of Jefferies ($15.00 per share target)Kyle Peterson of Needham ($14.00 per share target)Ashish Sabadra of RBC Capital ($12.00 per share target)George Tong of Goldman Sachs ($11.00 per share target)Manav Patnaik of Barclays ($11.00 per share target)Andrew Steinerman of J.P. Morgan ($10.00 per share target) (source: TipRanks) Additionally, the sale price is well below DNB’ 52-week high of $12.95 per share, and thus the deal appears highly opportunistic. “We are investigating whether the DNB Board of Directors acted in the best interests of DNB shareholders in approving the sale,” explained Joshua Fruchter, a founding partner of Wohl & Fruchter. “This includes whether the price agreed upon is fair to DNB shareholders, as well as whether all material information regarding the transaction has been fully disclosed.” About Wohl & Fruchter Wohl & Fruchter LLP has for over a decade been representing investors in litigation arising from fraud and other corporate misconduct, and recovered hundreds of millions of dollars in damages for investors. Please visit our website, www.wohlfruchter.com, to learn more about our Firm, or contact one of our partners. Contact:Wohl & Fruchter LLPJoshua E. Fruchter Toll Free 866.833.6245alerts@wohlfruchter.com www.wohlfruchter.com

Related News